• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Laura A. Lambert, MD, FACS

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
37 4.9 out of 5 Patient Rating

Languages Spoken: English

Dr. Laura Lambert is a Professor of Surgery and Director of the Peritoneal Malignancy Program at the University of Utah. Dr. Lambert specializes in the care of patients requiring surgical treatment related to peritoneal carcinomatosis (cancer which has spread throughout the lining of the abdominal cavity) and gastrointestinal oncology. Dr. Lambert earned her undergraduate degree from Bowdoin College in Brunswick, Maine, and medical degree from Harvard Medical School in Boston Massachusetts. Her general surgery residency was done at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, which was followed by a two-year fellowship in surgical oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas. She obtained her board certification in hospice and palliative medicine in 2012 at the University of Massachusetts in Worcester, Massachusetts. Dr. Lambert joined the faculty at the University of Utah in 2018. Her main clinical focus is the surgical management of peritoneal carcinomatosis and the use of hyperthermic (heated) intraperitoneal chemotherapy (HIPEC). She has published and spoken extensively on HIPEC as well as the surgeon’s role in comprehensive palliative care.

Clinical Locations

Huntsman Cancer Hospital

801-587-4415

Fax: (801) 585-3846

1950 Circle of Hope
Salt Lake City, UT  84112
Map

Specialties

  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Peritoneal Mesothelioma
  • Appendiceal Cancer
  • Oncology Surgery

Board Certification and Academic Information

Academic Departments Surgery - Professor (Clinical)
Academic Divisions General Surgery
Board Certification American Board of Hospice & Palliative Medicine
American Board of Surgery

Patient Rating

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Learn About Our Survey

Likelihood of recommending care provider

4.9/ 5

Care provider's explanation of condition/problem

4.9/ 5

Care provider's effort to include me in decisions

4.9/ 5

Wait time at clinic

4.7/ 5

Care provider's concern for questions & worries

4.9/ 5

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

UofU Patient November 17, 2022
Huntsman Cancer Institute

5 out of 5 stars

Dr. Lambert and Dr. Achers were both excellent care providers. Both showed genuine concern for my condition, were aggressive, moving forward, and did a great job explaining what was to take place, now and in the future, as well post-op follow up. I felt like I was in great hands.

UofU Patient October 29, 2022
Huntsman Cancer Institute

4 out of 5 stars

Knowledgeable, herbal skills excellent, shared review very well.

UofU Patient October 29, 2022
Huntsman Cancer Institute

5 out of 5 stars

I had questions, but they were all answered and addressed. I was completely satisfied.

UofU Patient October 08, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr Lambert is great, answered all my questions and I am certainly so VERY glad she is to be my surgeon. Truly

UofU Patient September 07, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Lambert was very thorough in discussing with me all my options related to my planned abdominal surgery. She took my concerns seriously.

UofU Patient August 18, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr Lambert is an excellent, caring doctor.

UofU Patient August 08, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Lambert was able to immediately schedule placement of stents in my ureters, which procedure took place the following day.

UofU Patient July 22, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Lambert is knowledgeable and up-to-date with the latest developments In her field. She is also the nicest doctor I have ever met!

UofU Patient July 15, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Lambert was so kind and caring. She answered our questions in a way that we could understand. We didn't feel rushed at all and felt like all of our concerns were addressed.

UofU Patient June 11, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Great

UofU Patient June 09, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Both the resident and Dr. Lambert were very thorough and attentive. She was well-informed about my case and offered a good plan for monitoring my disease.

UofU Patient June 04, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

I was so thankful to meet Dr Lambert, I feel genuinely strong about her opinions and plans my ongoing care. I felt so at ease just talking with her.

UofU Patient May 21, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Explained treatment options very well.

UofU Patient May 19, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

This visit did not include a discussion about treatment or any decision making-so my response is more indicative of past experience.

UofU Patient April 28, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Blumhagen and Dr. Lambert are the very best! The Huntsman is lucky to have them!

UofU Patient April 14, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

I was so impressed with Dr. Lampert. She took the time to really look at my charts before she even entered the room. She gave me a detailed analysis of my specific situation and then allowed me to ask whatever questions I had. She told me that she was available if I wanted to contacted her with questions or concerns. She also told me my regular physician or my oncologist could do the same.

UofU Patient March 26, 2022
HUNTSMAN CANCER CENTER

4 out of 5 stars

Once again I couldn't hear my doctors voice so we completed the visit a regular telephone conversation which went well. It would have been nice to have an extra day or two to make arrangements and have a test done prior to surgery. I had a hard time getting by an appointment in time to have results sent to huntsman before surgery.

UofU Patient March 09, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Lambert is very thorough, listens to my comments and concerns and gives me excellent feedback. She is thorough, kind, listens, and educates me. I highly recommend her and know I am in the best of hands.

UofU Patient January 15, 2022
HUNTSMAN CANCER CENTER

4 out of 5 stars

All professionals were kind, empathetic and explained treatment well. Each person that saw me handed me off to the next person. I never wondered who and when would see me next at my appointment.

UofU Patient December 19, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

I'm having gastrointestinal issues and she put in an order for me to see the gastrointestinal doctor. I'm waiting for a call to schedule a call appointment.

UofU Patient December 17, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Good

UofU Patient December 02, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Lambert took a lot of time with us to discuss all facets of the procedure.

UofU Patient October 25, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr Lambert is easy to talk with and obviously cares a great deal for my welfare

UofU Patient October 22, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Answered all questions.

UofU Patient October 06, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr Lambert is a wonderful caring doctor, I received outstanding care from her and her team.

UofU Patient September 30, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

I was very well informed.

UofU Patient August 28, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Once again, I was totally impressed. Dr. Lambert put me at ease over all that was going to take place. She reassured me that she would take good care of me and we would be able to get the problem fixed and taken care of, and that I would feel so much better after it was all over. It was reassuring to hear her confidence and all the others I came in contact with. Everyone was nice with smiles on their faces.

UofU Patient August 21, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Great

UofU Patient August 16, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Lambert is by far the best!

Dr. Laura Lambert is a Professor of Surgery and Director of the Peritoneal Malignancy Program at the University of Utah. Dr. Lambert specializes in the care of patients requiring surgical treatment related to peritoneal carcinomatosis (cancer which has spread throughout the lining of the abdominal cavity) and gastrointestinal oncology. Dr. Lambert earned her undergraduate degree from Bowdoin College in Brunswick, Maine, and medical degree from Harvard Medical School in Boston Massachusetts. Her general surgery residency was done at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, which was followed by a two-year fellowship in surgical oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas. She obtained her board certification in hospice and palliative medicine in 2012 at the University of Massachusetts in Worcester, Massachusetts. Dr. Lambert joined the faculty at the University of Utah in 2018. Her main clinical focus is the surgical management of peritoneal carcinomatosis and the use of hyperthermic (heated) intraperitoneal chemotherapy (HIPEC). She has published and spoken extensively on HIPEC as well as the surgeon’s role in comprehensive palliative care.

Academic Locations

Board Certification and Academic Information

Academic Departments Surgery - Professor (Clinical)
Academic Divisions General Surgery
Board Certification American Board of Hospice & Palliative Medicine
American Board of Surgery

Education History

Fellowship University of Texas MD Anderson Cancer Center
Surgical Oncology
Administrative Fellow, 2006
Fellowship University of Texas MD Anderson Cancer Center
Surgical Oncology
Fellow, 2004
Chief Resident Dartmouth-Hitchcock Medical Center
General Surgery
Chief Resident, 2003
Residency Dartmouth-Hitchcock Medical Center
General Surgery
Resident, 2002
Internship Dartmouth-Hitchcock Medical Center
General Surgery
Intern, 1997
Professional Medical Harvard Medical School
Medicine
M.D., 1996
Undergraduate Bowdoin College
German & Economics
B.A., 1988

Selected Publications - Journal Articles

Journal Article

  1. Kubi B, Nudotor R, Fackche N, Nizam W, Cloyd JM, Grotz TE, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Patel SH, Lambert LA, Abbott DE, Vande Walle KA, Raoof M, Lee B, Maithel SK, Staley CA, Johnston FM, Greer JB (2021). Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis. Ann Surg Oncol, 28(8), 4499-4507.
  2. Bleicher J, Lambert LA (2021). A Palliative Approach to Management of Peritoneal Carcinomatosis and Malignant Ascites. Surg Oncol Clin N Am, 30(3), 475-490.
  3. Bleicher J, Lambert LA, Scaife CL, Colonna A (2021). Current management of malignant bowel obstructions: a survey of acute care surgeons and surgical oncologists. Trauma Surg Acute Care Open, 6(1), e000755.
  4. Bleicher J, Place A, Schoenhals S, Luppens CL, Grudziak J, Lambert LA, McCrum ML (2021). Drivers of Moral Distress in Surgical Intensive Care Providers: A Mixed Methods Study. J Surg Res, 266, 292-299.
  5. Fackche N, Schmocker RK, Kubi B, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Powers B, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Gamblin TC, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB (2021). The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative. J Gastrointest Surg.
  6. Lee RM, Gamboa AC, Turgeon MK, Zaidi MY, Kimbrough C, Leiting J, Grotz T, Lee AJ, Fournier K, Powers B, Dineen S, Baumgartner JM, Veerapong J, Mogal H, Clarke C, Wilson G, Patel S, Hendrix R, Lambert L, Pokrzywa C, Abbott DE, LaRocca CJ, Raoof M, Greer J, Johnston FM, Staley CA, Cloyd JM, Maithel SK, Russell MC (2020). A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC. J Surg Oncol, 123(1), 187-195.
  7. Powers BD, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Maithel SK, Patel S, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Johnston FM, Greer J, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Imanirad I, Dessureault S, Dineen SP (2020). Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study. Ann Surg Oncol, 27(13), 4883-4891.
  8. Turgeon MK, Gamboa AC, Lee RM, Zaidi MY, Kimbrough C, Grotz T, Fournier K, Powers B, Dineen S, Veerapong J, Clarke C, Mogal H, Patel SH, Lambert L, Ronnekleiv-Kelly S, Raoof M, Fackche N, Greer JB, Staley CA, Cloyd JM, Maithel SK, Winer JH (2020). The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC. Ann Surg Oncol, 27(13), 4894-4907.
  9. Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, Leiting J, Fournier K, Lee AJ, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Mogal H, Patel SH, Lee TC, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA (2020). Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol, 27(13), 4980-4995.
  10. Hbner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K, Bell J, Bristow R, Guiral DC, Fagotti A, Falco LFR, Glehen O, Lambert L, Mack L, Muenster T, Piso P, Pocard M, Rau B, Sgarbura O, Somashekhar SP, Wadhwa A, Altman A, Fawcett W, Veerapong J, Nelson G (2020). Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special considerations. Eur J Surg Oncol, 46(12), 2311-2323.
  11. Roife D, Powers BD, Zaidi MY, Staley CA, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lee B, Blakely A, Greer J, Johnston FM, Laskowitz D, Dessureault S, Dineen SP (2020). CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative. Ann Surg Oncol, 27(13), 4996-5004.
  12. Wiseman JT, Abdel-Misih S, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Eng O, Fackche N, Greer J, Pawlik TM, Cloyd JM (2020). A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies. Surg Oncol, 37, 101492.
  13. Kubi B, Gunn J, Fackche N, Cloyd JM, Abdel-Misih S, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Patel SH, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Maithel SK, Staley CA, Johnston FM, Wang NY, Greer JB (2020). Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Surg Res, 255, 475-485.
  14. Eng OS, Blakely AM, Lafaro KJ, Fournier KF, Fackche NT, Johnston FM, Dineen S, Powers B, Hendrix R, Lambert LA, Ronnekleiv-Kelly S, Walle KV, Grotz TE, Leiting JL, Patel SH, Dhar VK, Baumgartner JM, Lowy AM, Clarke CN, Mogal H, Zaidi MY, Staley CA, Kimbrough C, Cloyd JM, Lee B, Raoof M (2020). Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways. J Surg Oncol, 122(5), 980-985.
  15. Nevo ON, Lambert L (2020). Start the Right Way: A Foundation for Improving Connection to Service and People in Medical Education. Mil Med, 185(Suppl 3), 46-51.
  16. Leiting JL, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dessureault S, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Zaidi MY, Patel SH, Ahmad SA, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, LaRocca CJ, Johnston FM, Greer J, Grotz TE (2020). Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative. World J Gastrointest Oncol, 12(7), 756-767.
  17. Beal EW, Suarez-Kelly LP, Kimbrough CW, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Lee B, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Dhar V, Lambert L, Hendrix RJ, Hays J, Abdel-Misih S, Cloyd JM (2020). Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review. J Clin Med, 9(3).
  18. Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, LaRocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM (2019). Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg, 219(3), 478-483.
  19. Wiseman JT, Kimbrough C, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Fackche N, Greer J, Pawlik TM, Abdel-Misih S, Cloyd JM (2019). Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? Ann Surg Oncol, 27(3), 783-792.
  20. Lee RM, Zaidi MY, Gamboa AC, Speegle S, Kimbrough CW, Cloyd JM, Leiting JL, Grotz TE, Lee AJ, Fournier KF, Powers BD, Dineen SP, Baumgartner J, Veerapong J, Clarke CN, Sussman JJ, Patel S, Hendrix RJ, Lambert LA, Vande Walle KA, Abbott DE, LaRocca CJ, Raoof M, Fackche N, Johnston FM, Staley CA, Maithel SK, Russell MC (2019). What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative. Clin Colorectal Cancer, 19(1), e1-e7.
  21. Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK (2019). Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol, 27(1), 134-146.
  22. Hendrix RJ, Kassira JP, Lambert LA (2019). Elevated Maximum Core Body Temperature During Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is Associated with Increased Postoperative Complications. Ann Surg Oncol, 27(1), 232-239.
  23. Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH (2019). Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. J Gastrointest Surg, 24(1), 155-164.
  24. Zaidi MY, Lee RM, Gamboa AC, Speegle S, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Kelly KJ, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Hendrix RJ, Lambert L, Ronnekleiv-Kelly S, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Fackche N, Russell MC, Maithel SK, Staley CA 3rd (2019). Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative. Ann Surg Oncol, 27(1), 156-164.
  25. Lee TC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Zaidi MY, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Greer J, Patel SH (2019). Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study. J Gastrointest Surg, 24(1), 165-176.
  26. Leiting JL, Day CN, Harmsen WS, Cloyd JM, Abdel-Misih S, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapongh J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Morris MC, Hendrix RJ, Lambert LA, Abbott DE, Pokrzywa C, Raoof M, Eng O, Johnston FM, Greer J, Grotz TE (2020). The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. Int J Hyperthermia, 37(1), 1182-1188.
  27. Hendrix RJ, Lambert LA (2019). ASO Author Reflections: Intraoperative Fluid Restriction During CRS-HIPEC-Less is More. Ann Surg Oncol, 26(Suppl 3), 575-576.
  28. Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Dessureault S, Clarke C, Mogal H, Zaidi MY, Russell MC, Patel SH, Sussman JJ, Dhar V, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Greer JB, Fackche N, Lowy AM, Kelly KJ (2019). Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study. Ann Surg Oncol, 26(7), 2234-2240.
  29. Lambert LA (2019). Invited Commentary. J Am Coll Surg, 228(6), 851.
  30. Zhu X, Salhab M, Tomaszewicz K, Meng X, Mathew C, Bathini V, Switzer B, Walter O, Cosar EF, Wang X, Lambert LA, Hutchinson LM (2018). Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms. Hum Pathol, 85, 260-269.
  31. Hendrix RJ, Damle A, Williams C, Harris A, Spanakis S, Lambert DH, Lambert LA (2018). Restrictive Intraoperative Fluid Therapy is Associated with Decreased Morbidity and Length of Stay Following Hyperthermic Intraperitoneal Chemoperfusion. Ann Surg Oncol, 26(2), 490-496.
  32. Lambert LA, Wiseman J (2018). Palliative Management of Peritoneal Metastases. Ann Surg Oncol, 25(8), 2165-2171.
  33. Lambert LA, Hendrix RJ (2018). Palliative Management of Advanced Peritoneal Carcinomatosis. Surg Oncol Clin N Am, 27(3), 585-602.

Conference Proceedings

  1. Hbner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K, Bell J, Bristow R, Guiral DC, Fagotti A, Falco LFR, Glehen O, Lambert L, Mack L, Muenster T, Piso P, Pocard M, Rau B, Sgarbura O, Somashekhar SP, Wadhwa A, Altman A, Fawcett W, Veerapong J, Nelson G (2020). Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management. Eur J Surg Oncol, England, 46(12), 2292-2310.

Letter

  1. Lambert LA (2017). Medical Assistance in Dying. [Letter to the editor]. N Engl J Med, 377(9), 897.

Huntsman Cancer Institute News

Delivering Chemo Directly to Cancer Cells with HIPEC

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Price Estimate
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

Appointment Scheduling:
801-213-9500

Hospital Operator:
801-581-2121

En Español:
801-646-5914

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2023 University of Utah Health